MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak

BACKGROUND: The onset of the SARS-CoV-2 pandemic has resulted in ever-increasing casualties worldwide, and after 15 months, standard therapeutic regimens are yet to be discovered. MAIN BODY: Due to the regenerative and immunomodulatory function of MSCs, they can serve as a suitable therapeutic optio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamalkhah, Monire, Asaadi, Yasaman, Azangou-Khyavy, Mohammadreza, Khanali, Javad, Soleimani, Masoud, Kiani, Jafar, Arefian, Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061879/
https://www.ncbi.nlm.nih.gov/pubmed/33888147
http://dx.doi.org/10.1186/s12967-021-02840-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061879/
https://www.ncbi.nlm.nih.gov/pubmed/33888147
http://dx.doi.org/10.1186/s12967-021-02840-3

Ejemplares similares